UBASH3B and triple-negative breast carcinoma: UBASH3B has also emerged as a key oncogenic player in breast cancer progression, exhibiting distinct roles in both estrogen-receptor (ER)-positive breast cancer [79] and triple-negative breast cancer (TNBC) [47].